Abstract: Compositions having enhanced analgesic and myotonolytic activity comprising as active agents (a) an analeptically active quinazolinone and (b) a centrally acting myotonolytic.
Abstract: Dibenzazepine derivatives in free base form or in pharmaceutically acceptable acid addition salt form are useful as neuroleptic, antidepressant, sleep-inducing, sleep-promoting and sleep-prolonging agents.
Abstract: Compounds of formula I, ##STR1## wherein R is hydrogen, alkyl (C.sub.1-4) or hydroxyalkyl (C.sub.2-3), are useful as neuroleptics, sleep promoters, myotonolytics, and anti-depressants.
Abstract: The present invention concerns compounds of formula ##STR1## wherein X is O, S or NH; n is 1 or 2 and A is a 5-membered heterocyclic ring, wherein the bicyclic system may be substituted. The compounds are useful as myotonolytic and anti-hypertensive agents.
Abstract: Agents for lowering glucose levels in blood having the formula: ##STR1## wherein each R, independently, is hydrogen, C.sub.1-6 alkylcarbonyl or a group of the formula ##STR2## where R.sub.1 is hydrogen, C.sub.1-4 alkyl, C.sub.1-4 -alkoxy, halo or trifluoromethyl, andR.sub.2 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy or halo, with the proviso that when one R is hydrogen, the other R is not hydrogen.
Abstract: Disclosed are anthraquinone dyestuffs which, in free acid form, are of formula I, ##STR1## in which R signifies an alkyl radical of 6 to 24 carbon atoms, an unsubstituted cyclohexyl radical or a cyclohexyl radical substituted by one or more substituents selected from halogen atoms and alkyl and alkoxy radicals,R.sub.1 and R.sub.2, independently, each signifies an alkyl radical of 1 to 6 carbon atoms,X signifies --O-- or a direct bond,ring A is unsubstituted or substituted by one or two halogen atoms, hydroxyl groups or C.sub.1-4 alkyl or alkoxy groups,their production and use in the dyeing of anionic dyeable substrates, particularly natural and synthetic polyamide fibers.
Abstract: This disclosure describes compounds of the formula ##STR1## wherein n is 3, 5 or 7, andeach R is lower alkyl having 1 to 4 carbon atoms, or pharmaceutically acceptable acid addition salts thereof, which are useful as anti-diabetic agents in particular glucagon inhibiting agents.
Abstract: The myotonolytic use of compounds of formula I ##STR1## wherein R is hydrogen, acetyl or a group of formula IIR'--O--CO-- IIwherein R' is alkyl(C.sub.1-8); phenyl; phenyl substituted in the 4-position with halogen, alkoxy(C.sub.1-4) or alkyl(C.sub.1-4); phenylalkyl; or phenylalkyl in which the phenyl group is substituted in the 4-position with halogen, alkoxy(C.sub.1-4) or alkyl(C.sub.1-4).
Abstract: Dibenzazepine derivatives in free base form or in pharmaceutically acceptable acid addition salt form are useful as neuroleptic, antidepressant, sleep-inducing, sleep-promoting and sleep-prolonging agents.
Abstract: The invention discloses certain 1-phenyl-pyrazole derivatives having pharmacological activity in animals and useful as glucagon inhibiting agents. Nearly all of the compounds of this invention are prepared by cyclization of a phenyl hydrazine compound with a 1,1,3,3-tetra-C.sub.1-4 -alkoxy-propane compound.
Abstract: The present invention relates to a process for stabilizing organic polymeric materials comprising incorporating therein a benzofuran(2)one compound or indolin(2)one compound containing at least two benzofuran(2)one or indolin(2)one nuclei.
Type:
Grant
Filed:
February 4, 1980
Date of Patent:
July 6, 1982
Assignee:
Sandoz Ltd.
Inventors:
Hans Hinsken, Horst Mayerhoefer, Wolfgang Mueller, Hermann Schneider
Abstract: either(i) X is --CH.sub.2 -- and n is 0, 1, 2 or 3 or(ii) X is --CO-- and n is 1, 2 or 3 or(iii) X is --O-- and n is 2 or 3,R.sub.2 is hydrogen, halogen, trifluoromethyl or alkyl of 1 to 4 carbon atoms,R.sub.3 is hydrogen, halogen, trifluoromethyl, or alkyl or alkoxy of 1 to 4 carbon atoms,R.sub.4 is hydrogen, or alkyl or alkoxy of 1 to 4 carbon atoms,andR.sub.5 is hydrogen, alkyl of 1 to 4 carbon atoms or alkenyl of 3 or 4 carbon atoms, with the proviso that, when R.sub.2 is hydrogen, R.sub.5 is hydrogen,are useful for inducing sleep and treating psychoses and depressions.
Abstract: This invention provides a new tranquillizing use of thiazoline and imidazoline derivatives and novel pharmaceutical compositions for such use.
Abstract: Aqueous dispersions of an oxidized microcrystalline wax, optionally together with one or more non-oxidized paraffins, in which a cationic surfactant is used as dispersing agent may be applied to textile substrates by impregnation or exhaust processes. The treated textile substrates, particularly knitted goods, have improved sewability and are less liable to damage by high-speed sewing machines.
Abstract: This invention provides a new antidepressive use of thiazoline and imidazoline derivatives and novel pharmaceutical compositions for such use.
Abstract: The present invention relates to a process for stabilizing organic polymeric materials comprising incorporating therein a benzofuran (2) one or indolin (2) one compound as stabilizer. Such stabilized polymeric materials are stabilized against degradation during the polymer processing.
Type:
Grant
Filed:
February 4, 1980
Date of Patent:
April 20, 1982
Assignee:
Sandoz Ltd.
Inventors:
Hans Hinsken, Horst Mayerhoefer, Wolfgang Mueller, Hermann Schneider
Abstract: Compounds of formula I, ##STR1## wherein R is hydrogen, alkyl (C.sub.1-4) or hydroxyalkyl (C.sub.2-3), are useful as neuroleptics, sleep promoters, myotonolytics, and anti-depressants.
Abstract: Aryl phosphonites and thiophosphonites of the formula, ##STR1## in which the or each R, independently, is alkyl, alkoxy, chlorine or dialkylamino, there being at the most one dialkylamino group, at the 4-position and unaccompanied by any other substituents, on the benzene nucleus,n is zero, 1, 2 or 3,each X, independently, is oxygen or sulphur,and each R.sub.1, independently, is alkyl or optionally substituted phenyl,are useful as antioxidants. Organic material, e.g. polypropylene, which are susceptible to the degradative effects of oxygen, are treated with one or more of such compounds, e.g. by incorporation into the body of the organic material, in order to be stabilized against such effects.
Type:
Grant
Filed:
May 29, 1980
Date of Patent:
December 29, 1981
Assignee:
Sandoz Ltd.
Inventors:
Kurt Hofer, Rudolf Moesch, Guenther Tscheulin